Title:
MACROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/016986
Kind Code:
A1
Abstract:
The present invention relates to a macrocyclic inhibitor, a composition and a use thereof. In particular, the present invention relates to a compound as shown in formula (I), a pharmaceutical composition comprising the compound of the present invention, and a use thereof as an EGFR inhibitor in the treatment of cancer-related diseases.
Inventors:
LIU XIANGYONG (CN)
FU BANG (CN)
QIU CHANGYONG (CN)
SONG XIAODONG (CN)
REN WEI (CN)
WANG YIQIAN (CN)
CHEN JIE (CN)
BAI JINLONG (CN)
SUN YUN (CN)
ZHANG JIAN (CN)
ZHANG CHUNHUI (CN)
LI YINLONG (CN)
LIU LIJIA (CN)
GUO JING (CN)
LAN HONG (CN)
DING LIEMING (CN)
WANG JIABING (CN)
FU BANG (CN)
QIU CHANGYONG (CN)
SONG XIAODONG (CN)
REN WEI (CN)
WANG YIQIAN (CN)
CHEN JIE (CN)
BAI JINLONG (CN)
SUN YUN (CN)
ZHANG JIAN (CN)
ZHANG CHUNHUI (CN)
LI YINLONG (CN)
LIU LIJIA (CN)
GUO JING (CN)
LAN HONG (CN)
DING LIEMING (CN)
WANG JIABING (CN)
Application Number:
PCT/CN2023/103621
Publication Date:
January 25, 2024
Filing Date:
June 29, 2023
Export Citation:
Assignee:
BETTA PHARMACEUTICALS CO LTD (CN)
International Classes:
C07D498/18; A61K31/439; A61P35/00; C07D498/22
Domestic Patent References:
| WO2022011123A1 | 2022-01-13 |
Foreign References:
| CN114007698A | 2022-02-01 | |||
| CN114057771A | 2022-02-18 | |||
| CN114656482A | 2022-06-24 | |||
| CN114163454A | 2022-03-11 |
Download PDF:
Previous Patent: MESSAGE PROCESSING METHOD, COMMUNICATION SYSTEM AND RELATED APPARATUS
Next Patent: NUT LOLLIPOP FORMING APPARATUS AND METHOD
Next Patent: NUT LOLLIPOP FORMING APPARATUS AND METHOD